Healthcare at Kellogg

The Kellogg approach to healthcare management

The Kellogg School of Management is proud to offer an MBA with an emphasis in healthcare management. It’s based on the crucial understanding that healthcare in the United States is, at its core, a business.

Our innovative Program on Healthcare at Kellogg (HCAK), was purposefully designed to build upon this powerful reality by offering an MBA that specializes in courses at the intersection of business and policy. Central to this objective is offering a cutting-edge curriculum to help our students identify the intricacies of the public-private nature of healthcare.

Led by our renowned faculty and thought leaders, HCAK gives students a deep understanding of the regulatory, cultural and moral dimensions of healthcare, as well as the intricacies of product manufacturers, insurers and provider responsibilities. Regardless of prior background, students who choose Kellogg will become the next generation of industry leaders who have the ability to deliver meaningful business results.

Upcoming Events

37th Annual MacEachern Symposium
May 6, 2020 - Global Hub (Postponed until Spring 2021)

ANNUAL BIOTECH AND HEALTHCARE CASE COMPETITION
January 30, 2021 - Virtual
Contact
Craig Garthwaite
Faculty Director, HCAK
Email
Paul Campbell
Executive Director, HCAK
EMAIL
Julie Gertz
Program Development Manager
Email

Master the business of healthcare

Healthcare at Kellogg combines foundational theories with hands-on experiential learning. A key strength of the program is our cross-disciplinary curriculum coupled with a distinct emphasis on the public-private nature of healthcare today.

Academics & Student Experience

We empower students to become the next generation of healthcare leaders.

Faculty & Thought Leadership

Our faculty are renown experts at the intersection of healthcare, business and policy.

Executive Partnerships

Kellogg partners with healthcare industry leaders to maximize program opportunities and establish new insights.

Healthcare in the News

Historic financial decline hits doctors, dentists and hospitals — despite covid-19 — threatening overall economy

Article quotes Professor Craig Garthwaite who questions how efficient doctors can be in a world of social distancing. (The Washington Post)

Putting A Price On COVID-19 Treatment Remdesivir

Article quotes Professor Craig Garthwaite who says that Remdesivir, a drug that will help combat the coronavirus, should be generously priced so that drug companies will be encouraged to keep developing a total cure. (NPR)

The Price of Innovation

Podcast features Professor Craig Garthwaite who discusses the relationship between drug prices and the lack of innovation in the industry. (Tradeoffs)